Centessa Pharmaceuticals plc Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Centessa Pharmaceuticals plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Centessa Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$42.6M, a 10.1% decline year-over-year.
  • Centessa Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$161M, a 2.44% decline year-over-year.
  • Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2023 was -$151M, a 30.1% increase from 2022.
  • Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2022 was -$216M, a 43.3% increase from 2021.
  • Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2021 was -$381M, a 3474% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.